Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Melanotan-2 vs Sildenafil: Head-to-Head Clinical Comparisons

Direct comparison trials reveal where MT-2 outperforms PDE5 inhibitors and where it doesn't. The 2003 European Urology study tested both compounds in sequence: participants received sildenafil 100mg on demand for four weeks, followed by a washout, then MT-2 0.

This comparison does not assign a generated winner or score.

  • Direct comparison trials reveal where MT-2 outperforms PDE5 inhibitors and where it doesn't. The 2003 European Urology study tested both compounds in sequence: participants received sildenafil 100mg on demand for four weeks, followed by a washout, then MT-2 0.075mg/kg for four weeks. Men with psychogenic ED (confirmed by normal nocturnal erections) showed 78% response to MT-2 versus 52% to sildenafil. Men with organic ED (diabetic neuropathy, post-prostatectomy) showed 41% response to sildenafil versus 38% to MT-2. No meaningful difference.
  • The mechanism explains this pattern. Psychogenic ED involves disrupted arousal signaling from the brain to the spinal erection centres. MT-2 directly corrects that pathway. Organic ED involves damaged vascular or nerve tissue. MT-2 can't compensate for absent physical structures. Sildenafil works when smooth muscle and endothelium are intact but nitric oxide signaling is weak; it fails when vessels are occluded or nerves are severed.
  • Side effect profiles differ sharply. Sildenafil commonly causes headache (16% incidence), flushing (10%), and visual disturbances (3%). MT-2 causes nausea (40–50% during dose escalation), spontaneous erections unrelated to arousal context (reported as 'inappropriate erections' in 22% of participants), and transient increases in blood pressure (5–10 mmHg systolic). The nausea typically resolves after the first three administrations; the spontaneous erections persist as long as the peptide is active.
  • One finding matters for practical use: MT-2's effect doesn't require sexual stimulation. Men in the trials reported erections occurring during non-sexual activities. Driving, working, sleeping. This is both the therapeutic benefit (restoration of spontaneous erectile capacity) and the primary inconvenience. Sildenafil only works in the presence of arousal; MT-2 bypasses that gate entirely.
More references

Related material